D2N2 is home to 56% of the total East Midlands medical technologies cluster, which is the third largest in the UK. This cluster is growing in number through the work of Medilink East Midlands, the life science and industry association, who help life science companies to establish, develop and grow.
Life science is broad ranging and includes a number of disciplines including biology, sport science, biochemistry and pharmaceutical development are some of the wide variety of sub sciences. Demand in the life sciences sector is being driven by developing technologies, aging and more informed population as well as growing global wealth. The sector is particularly important in Nottingham where it is a key driver of innovation. D2N2 is home to over 200 medical technology firms.
D2N2 is home to some of the largest life science businesses such as Alliance Boots and Pennine Healthcare. As well as these large businesses we are home to significant business incubators such as Medicity and Biocity.
Biocity is the largest collective space for bioscience firms with laboratory space for businesses to work in to develop their product, research and further their business in a productive environment. Biocity has also recently been granted £6.5M from D2N2, towards their £30M expansion project which is due to open in spring 2017and create 700 jobs over the next 30 years.
Boots UK headquarters are based on the Nottingham Enterprise Zone, Boots site, in Nottingham. Manufacturing pharmaceutical products in the historic roots of the business which employs a significant number of staff on (c.11,000 staff) site. It is a nationally significant sector and provides an opportunity for niche producers and university spin-outs.
The manufacture of medical and wearable devices, whilst a relatively small sub-sector, is a particularly high value sub-sector of manufacturing with a high level of R&D activities. To find out more about MediCity click here.
Employment 2012: 7,200 (BRES)
 Please note, employment at Alliance Boots does not fall within our definition of the Life Sciences sector and is classified as ‘Dispensing chemist in specialist stores’ in the Standard Industrial Classification codes
Through the D2N2 Growth Hub and the UI4G (Unlocking Investment for Growth) programme a number of businesses have been supported within the sector and these case studies are linked below:
The INSTILS project from Medilink East Midlands has recently been contracted to receive EU funding to deliver the project which will allow SMEs to access high value cutting edge expertise from- sector specific specialists and services, local research entities, other life sciences businesses and other sectors. Access to this support will ensure that businesses can grow by introducing new products and services that benefit from:-innovations, identified clinical needs, incorporation or utilisation of cutting edge technologies and early incorporation of market understanding, regulatory and IP management strategies.
To find out more about the programme please contact D2N2 Growth Hub on 0333 006 9178 or email@example.com